Organ or Tissue Function – Page 2

Gazyva Shows Promising Results in Lupus Nephritis Treatment, Paving Way for Expanded Indication

7 months ago talkbio0Tagged Autoimmune Diseases, Gazyva, genentech, Kidney Failure, Chronic, Lupus Nephritis, Phase III REGENCY study, Renal function, renal response, Roche (company)

Gazyva, lupus nephritis, Roche, Genentech, Phase III REGENCY study, complete renal response, autoimmune disease, kidney function, end-stage kidney disease.

Pfizer and Valneva Report Strong Immune Responses from Second Lyme Disease Vaccine Booster

8 months ago talkbio0Tagged Immune response, Lyme Disease, Pfizer, Phase 2 Trials, Submission, United States Food and Drug Administration, Vaccines, Valneva, VLA15

Lyme disease, vaccine, Pfizer, Valneva, VLA15, booster, immune response, Phase 2 trials, FDA submission

FDA Approves Updated Covid Vaccines for Fall Season: What You Need to Know

8 months ago talkbio0Tagged Approved, aspects of adverse effects, COVID19 (disease), fall season, Immune response, KP.2, Muscle strain, Timing, United States Food and Drug Administration, Vaccination, Vaccines

Covid-19 vaccines, FDA approval, updated vaccines, fall season, KP.2 strain, vaccination timing, immunity, side effects.

England’s NICE Approves Theramex’s Uterine Fibroids Treatment

8 months ago talkbio0Tagged Antagonist muscle action, gonadorelin, hormonal add-back therapy, linzagolix, Nance-Horan syndrome, Nitroglycerin/Sodium Citrate/Ethanol Solution, Theramex, Uterine Fibroids, women 's, Yselty

NICE, Theramex, uterine fibroids, linzagolix, Yselty, GnRH antagonist, hormonal add-back therapy, NHS, women’s health

Pfizer Strengthens Case for RSV Vaccine with Positive Data in Vulnerable Adults

8 months ago talkbio0Tagged Abrysvo, Clinical Trials, Immune response, immunocompromised adults, Pfizer, regulatory approval, Respiratory syncytial virus, Vaccines

Pfizer, RSV vaccine, Abrysvo, immunocompromised adults, clinical trial, immune responses, regulatory approval

Moderna’s Combination Flu and COVID-19 Vaccine Shows Promising Results in Late-Stage Trial

11 months ago talkbio0Tagged COVID19 (disease), Immune response, Late-Stage Trial, Moderna, Respiratory viruses, SARS-CoV-2, Vaccines, Vaccines, Combined

Moderna, flu vaccine, COVID-19 vaccine, combination vaccine, mRNA-1083, late-stage trial, immune response, influenza, SARS-CoV-2, respiratory viruses

AstraZeneca’s COVID-19 Antibody Treatment Shows Promising Results in Immunocompromised Individuals

11 months ago talkbio0Tagged Antibodies, AstraZeneca, Clinical Trials, COVID19 (disease), Enhance (action), Immune response, Immunocompromised Host, individuals, Monoclonal Antibodies, Neutralization (Chemistry), Protection, Virus

AstraZeneca, COVID-19, antibody treatment, immunocompromised individuals, enhanced protection, clinical trials, monoclonal antibodies, virus neutralization, immune response.